Literature DB >> 6467848

The natural history of rheumatoid arthritis: a fifteen year follow-up study. The prognostic significance of features noted in the first year.

J J Rasker, J A Cosh.   

Abstract

One hundred patients with definite or classical rheumatoid arthritis have been followed since the early months of their disease; after 15 years the 65 surviving patients were reviewed. Their functional capacity had fallen by comparison with reviews made 3 and 11 years after onset, but half were still unimpaired or only moderately so (grade 1 and 2). The number of affected joints had risen to an average of 8 joints in men and 13 in women, but the ESR and the titre of the Rose test were lower than in the first year. Haemoglobin levels had risen in men, but fallen in women. The first-year titre of the Rose test proved to be of great prognostic significance, regarding ARA grading and number of affected joints after 15 years, but it did not correlate with the functional capacity. However, the functional capacity at 3 years correlated significantly with its value at 11 and 15 years. Patients with rheumatoid nodules were significantly worse than the remainder in many respects. A positive Schirmer test, showing diminished tear secretion, did not relate to any of the clinical parameters. The medical and surgical treatment is briefly reviewed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6467848     DOI: 10.1007/bf02715690

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  9 in total

1.  COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.

Authors:  J J DUTHIE; P E BROWN; L H TRUELOVE; F D BARAGAR; A J LAWRIE
Journal:  Ann Rheum Dis       Date:  1964-05       Impact factor: 19.103

2.  Medical and social aspects of the treatment of rheumatoid arthritis; with special reference to factors affecting prognosis.

Authors:  J J DUTHIE; M THOMPSON; M M WEIR; W B FLETCHER
Journal:  Ann Rheum Dis       Date:  1955-06       Impact factor: 19.103

3.  Therapeutic criteria in rheumatoid arthritis.

Authors:  O STEINBROCKER; C H TRAEGER; R C BATTERMAN
Journal:  J Am Med Assoc       Date:  1949-06-25

4.  The clinical features of rheumatoid arthritis. Prognostic indices.

Authors:  C RAGAN
Journal:  JAMA       Date:  1962-08-25       Impact factor: 56.272

5.  Sheep cell agglutination test for rheumatoid arthritis; a clinico-pathological study.

Authors:  J BALL
Journal:  Ann Rheum Dis       Date:  1952-06       Impact factor: 19.103

6.  Radiological study of cervical spine and hand in patients with rheumatoid arthritis of 15 years' duration: an assessment of the effects of corticosteroid treatment.

Authors:  J J Rasker; J A Cosh
Journal:  Ann Rheum Dis       Date:  1978-12       Impact factor: 19.103

7.  Significance of positive tests for rheumatoid factor in the prognosis of rheumatoid arthritis. A follow-up study.

Authors:  A Cats; H M Hazevoet
Journal:  Ann Rheum Dis       Date:  1970-05       Impact factor: 19.103

8.  Onset, early stages, and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11-year follow-up.

Authors:  R K Jacoby; M I Jayson; J A Cosh
Journal:  Br Med J       Date:  1973-04-14

9.  Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis.

Authors:  J J Rasker; J A Cosh
Journal:  Ann Rheum Dis       Date:  1981-04       Impact factor: 19.103

  9 in total
  15 in total

Review 1.  Measuring performance in clinical rheumatology.

Authors:  D L Scott; I Haslock
Journal:  Ann Rheum Dis       Date:  1990-01       Impact factor: 19.103

Review 2.  What should we hope to achieve when treating rheumatoid arthritis?

Authors:  D L Scott; T D Spector; T Pullar; B McConkey
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103

3.  Duration of rheumatoid arthritis influences the degree of functional improvement in clinical trials.

Authors:  D Aletaha; M M Ward
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

4.  Severity of rheumatoid arthritis: the SEVERA study.

Authors:  Rafic Baddoura; Souha Haddad; Hassane Awada; Abdel Fattah Al-Masri; Georges Merheb; Said Attoui; Jad Okais; Jamil Messayke; Fadi Ghandour
Journal:  Clin Rheumatol       Date:  2005-12-15       Impact factor: 2.980

Review 5.  The use of disease modifying antirheumatic drugs in the management of rheumatoid arthritis.

Authors:  L E Hart; P Tugwell
Journal:  Postgrad Med J       Date:  1989-12       Impact factor: 2.401

Review 6.  What happens to patients with rheumatoid arthritis? The long-term outcome of treatment.

Authors:  T D Spector; D L Scott
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

7.  Significance of rheumatoid factor isotypes in seronegative rheumatoid arthritis.

Authors:  F Eggelmeijer; H G Otten; H H de Rooy; M R Daha; F C Breedveld
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

8.  Synovial tissue macrophages and joint erosion in rheumatoid arthritis.

Authors:  G Yanni; A Whelan; C Feighery; B Bresnihan
Journal:  Ann Rheum Dis       Date:  1994-01       Impact factor: 19.103

9.  Pain and psychological health status over a 10-year period in patients with recent onset rheumatoid arthritis.

Authors:  Sigrid Odegård; Arnstein Finset; Petter Mowinckel; Tore K Kvien; Till Uhlig
Journal:  Ann Rheum Dis       Date:  2007-03-28       Impact factor: 19.103

10.  A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis.

Authors:  G M Hall; M Daniels; E C Huskisson; T D Spector
Journal:  Ann Rheum Dis       Date:  1994-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.